selected publications
- Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population. Gynecologic oncology reports. 2023 Academic Article GET IT
- Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature. Gynecologic oncology. 2023 Review GET IT
- Web-based tool for cancer family history collection: A prospective randomized controlled trial. Gynecologic oncology. 2023 Academic Article GET IT
-
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis.
PEC innovation.
2023
Academic Article
GET IT
Times cited: 1 - What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing. Cancer. 2022 Academic Article GET IT
-
Understanding Perceived Barriers to Colposcopy Follow-Up Among Underserved Women at an Urban Teaching Hospital: A Qualitative Study.
Journal of lower genital tract disease.
2022
Academic Article
GET IT
Times cited: 1 -
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2022
Review
GET IT
Times cited: 8 - Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting. Gynecologic oncology reports. 2022 Academic Article GET IT
-
Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis.
JCO clinical cancer informatics.
2021
Review
GET IT
Times cited: 1 -
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.
Gynecologic oncology.
2021
Review
GET IT
Times cited: 18 -
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic.
Gynecologic oncology.
2020
Academic Article
GET IT
Times cited: 17 -
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins.
Oncotarget.
2019
Academic Article
GET IT
Times cited: 3 -
Human Epididymis Secretory Protein 4 (HE4) Compromises Cytotoxic Mononuclear Cells via Inducing Dual Specificity Phosphatase 6.
Frontiers in pharmacology.
2019
Academic Article
GET IT
Times cited: 26 -
Less Is More: Minimally Invasive and Quality Surgical Management of Gynecologic Cancer.
Obstetrics and gynecology clinics of North America.
2019
Review
GET IT
Times cited: 1 -
HE4 suppresses the expression of osteopontin in mononuclear cells and compromises their cytotoxicity against ovarian cancer cells.
Clinical and experimental immunology.
2018
Academic Article
GET IT
Times cited: 7 - Therapeutic Molecular Biomarkers in Gynecological Cancers. Rhode Island medical journal (2013). 2015 Academic Article GET IT
-
Debulking surgery and intraperitoneal chemotherapy are associated with decreased morbidity in women receiving neoadjuvant chemotherapy for ovarian cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
2014
Academic Article
GET IT
Times cited: 3 -
Immediate postplacental IUD insertion at cesarean delivery: a prospective cohort study.
Contraception.
2012
Academic Article
GET IT
Times cited: 57